Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2010
08/18/2010EP2217617A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof
08/18/2010EP2217249A1 Inhibition of versican with sirna and other molecules
08/18/2010EP2004696B1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010EP1756571B1 Real time method of detecting acute inflammatory conditions
08/18/2010EP1461360B1 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours
08/18/2010EP1417222B1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
08/18/2010EP1307222B1 Non-human animal models of tolerance to hepatitis c virus immunogens
08/18/2010EP0723402B1 Senescent cell-derived inhibitors of dna synthesis
08/18/2010CN101809162A anti-glypican-3 antibody having improved kinetics in plasma
08/18/2010CN101809153A Factor involved in latent infection with herpesvirus, and use thereof
08/18/2010CN101809037A Human antibodies to human cd20 and method of using thereof
08/18/2010CN101809036A Fixed single injection dosage for ocrelizumab (2H7)
08/18/2010CN101809035A Antigen binding proteins capable of binding thymic stromal lymphopoietin
08/18/2010CN101809034A C3b antibodies and methods for the prevention and treatment of complement- associated disorders
08/18/2010CN101809033A Antibody having inhibitory activity on infection with hepatitis c virus (HCV), and use thereof
08/18/2010CN101808668A Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
08/18/2010CN101806804A Reagent for detecting acute myocardial infarction by immunological method and test strip
08/18/2010CN101805723A Anti-glutamate dehydrogenase protein monoclonal antibody, preparation method thereof and use thereof
08/18/2010CN101805406A Monoclonal antibody of human insulin-like growth factor binding protein-1, relative host cell, diagnostic reagent and diagnostic reagent kit
08/18/2010CN101805405A Anti-MFAP3L monoclonal antibody and use thereof in tumor detection
08/18/2010CN101805393A REPLIKIN peptides and uses thereof
08/18/2010CN101294147B Monoclone antibody of swine fever virus resistant wild strain E2 protein, preparation method and application thereof
08/18/2010CN101230333B Single-strain antibody for enrofloxacin and detecting set thereof
08/17/2010US7777024 Process for preparing a pentopyranosyl nucleic acid conjugate
08/17/2010US7777020 Nucleotide sequences derived from the env gene of HIV-1
08/17/2010US7777019 nucleic acid encoding the antibodies conjugated to radioisotope, drug, cytotoxic agent or biodrug; immunotoxin of use to treat cancer; immunoassay kit for detection of CD 22+ cancer cells; lymphoma
08/17/2010US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
08/17/2010US7777017 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo
08/17/2010US7777011 A preferred synthetic polypeptide having at least one antigenic site of a prion protein which only exist in nervous tissue of a mammal suffering from spongiform encephalopathy
08/17/2010US7777010 Recovering preferential protein from library; obtain genetically engineered cells, transform with vector coding preferential protein, express protein, isolate protein
08/17/2010US7777009 for modulation of chemokines; antiinflammatory agents; cancer
08/17/2010US7777008 ILT3 binding molecules and uses therefor
08/17/2010US7777007 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
08/17/2010US7776620 Hapten-carrier conjugates for treating and preventing nicotine addiction
08/17/2010US7776599 Method of enhancing homologous recombination of somatic cells and method of constructing specific antibody
08/17/2010US7776598 Methods and compositions for polypeptide engineering
08/17/2010US7776593 Hes6 as a marker of pancreatic endocrine cells
08/17/2010US7776585 Expression vector comprising nucleotide sequences coding integrin specific immunoglobulin for use as neovascularization inhibitor; antitumor agents
08/17/2010US7776560 Human tumor necrosis factor receptor TR9 antibody
08/17/2010US7776552 Drug screening; for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
08/17/2010US7776546 Using immunoglobulins specific to feline immunodeficiency virus envelope protein as a diagnostic indicator of RNA viral infection; immunodiagnostics
08/17/2010US7776544 Extraction and quantification of vitamins A & D in fluid samples
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/17/2010US7776330 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule
08/17/2010US7776328 Antibodies that bind to EphA2 and methods of use thereof
08/17/2010US7776327 Formulations that interact with and alter expression of epithelial cell tyrosine kinase
08/17/2010US7776321 A nucleic acid construct encoding the antigenic determinant of a mutable pathogen; an isolated cell containing the construct; genetic engineering; vaccination; immunotherapy
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2506580C Assay kit and antibody for human low molecular weight cd14
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
08/17/2010CA2269634C Reagents and methods useful for detecting diseases of the breast
08/17/2010CA2203679C Oral immunization with transgenic plants
08/12/2010WO2010091354A2 Akt tyrosine 176 phosphorylation cancer biomarker
08/12/2010WO2010091189A1 Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
08/12/2010WO2010091049A2 Diagnosis and treatment of cancer
08/12/2010WO2010090830A1 Modulation of sirt1 expression
08/12/2010WO2010090272A1 Remedy for chronic inflammation and antibody to be used therein
08/12/2010WO2010090079A1 Monoclonal antibody reacting specifically with stromelysin 1
08/12/2010WO2010090040A1 Monoclonal antibodies that recognize cholangiocarcinoma-specific sugar chain epitopes
08/12/2010WO2010089559A1 Cancer diagnosis and treatment
08/12/2010WO2010089411A2 Pd-1 antibodies and pd-l1 antibodies and uses thereof
08/12/2010WO2010089387A1 Production of oligoclonal mixtures of immunoglobulins in single cells
08/12/2010WO2010089340A2 Peptides protective against e. faecalis, methods and uses relating thereto
08/12/2010WO2010089126A2 Immunoglobulin glycosylation pattern analysis
08/12/2010WO2010088857A1 Crystal structure of amino terminal portion of influenza virus polymerase pa subunit and use thereof
08/12/2010WO2010088739A1 Sam-6 variants, target and methods of use
08/12/2010WO2010063818A3 Methods for selecting protease resistant polypeptides
08/12/2010WO2010034974A3 Tuberculosis vaccines targeted to cd40
08/12/2010WO2010007533A3 Human cytomegalovirus neutralizing antibodies and use thereof
08/12/2010US20100205690 Plants With Increased Yield
08/12/2010US20100205682 Humanized immunoglobulin loci
08/12/2010US20100205679 Animals, cells and methods for production of detectably-labeled antibodies
08/12/2010US20100204456 5-Fluoro-Uracil Immunoassay
08/12/2010US20100204455 Antibody Purification Process By Precipitation
08/12/2010US20100204454 Fc Variants with altered binding to FcRn
08/12/2010US20100204453 Antibodies to tumor associated proteins
08/12/2010US20100204444 Multifunctional protein simultaneously delivering antibodies and nanoparticles
08/12/2010US20100204442 Luminescent lanthanide (III) chelates, chelating agents and conjugates derived thereof
08/12/2010US20100204304 NOGO Receptor Binding Protein
08/12/2010US20100204128 Novel peptides
08/12/2010US20100204098 Peptides with antifungal activity
08/12/2010US20100204097 Therapeutic methods using a thymus peptide
08/12/2010US20100204059 CDR-Anchored Amplification Method
08/12/2010US20100204051 Hereditary Hemochromatosis Gene
08/12/2010US20100203651 Methods and compounds for phototransfer
08/12/2010US20100203631 Antibodies to alpha-synuclein
08/12/2010US20100203590 Antibodies that bind interleukin-4 receptor
08/12/2010US20100203560 IMMUNOASSAY FOR QUANTIFICATION OF AN UNSTABLE ANTIGEN SELECTED FROM BNP AND proBNP
08/12/2010US20100203559 Immuno-Based Botulinum Toxin Serotype A Activity Assays
08/12/2010US20100203510 Ppia marker for diagnosis of liver cancer and antibody, and screening method of compounds useful for inhibiting liver cancer
08/12/2010US20100203505 DOPAMINERGIC NEURON PROLIFERATIVE PROGENITOR CELL MARKER Msx1/2
08/12/2010US20100203503 Genetic polymorphisms associated with myocardial infarction and uses thereof
08/12/2010US20100203109 Methods and Compositions for Treating Melanoma
08/12/2010US20100203075 Chlamydia antigens
08/12/2010US20100203066 Polymeric linkers containing pyridyl disulfide moieties
08/12/2010US20100203064 Methods and compositions for modulating wound repair
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 1494